Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Singulair (Montelukast Sodium) Tablets
Company:  Merck Research Laboratories
Application No.:  020829
Approval Date: 2/20/1998


Date created: July 12, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.